This has subsequently been optimised and today CD45-/CD56+/CD81+/GD2+ cells by flow cytometry have been accepted to represent neuroblastoma cells (Swerts et al., 2004;Ferreira-Facio et al., 2013). Here, PTPRC is linked to neuroblastoma.